McCaffrey N, Kaambwa B, Currow DC, Ratcliffe J (2016) Health-related quality of life measured using the EQ-5D-5L: South Australian population norms
Further studies are needed to confirm the actual benefit of this molecule on metabolic liver diseases and define the best route of administration and the most appropriate dosage, allowing its use in clinical practice
While the benefits can be impressive, no treatment is without its risks
Does Belle package and ship your medication properly
Not even a standard drug screen
We wanted to look at this systematically in part to address the Catch-22 of third-party payers declining to cover these anti-obesity drugs because people quit them at a higher rate, when in truth some people stop the medications because coverage was terminated by the insurance company or the patient failed pre-authorization or they simply can't afford the out- of-pocket cost. Data is also important for clinicians and patients, he adds